JP2020512360A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020512360A5 JP2020512360A5 JP2019553219A JP2019553219A JP2020512360A5 JP 2020512360 A5 JP2020512360 A5 JP 2020512360A5 JP 2019553219 A JP2019553219 A JP 2019553219A JP 2019553219 A JP2019553219 A JP 2019553219A JP 2020512360 A5 JP2020512360 A5 JP 2020512360A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- substituted
- optionally substituted
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17163506.3 | 2017-03-29 | ||
| EP17163506 | 2017-03-29 | ||
| PCT/EP2018/057069 WO2018177825A1 (en) | 2017-03-29 | 2018-03-20 | Orthogonal protecting groups for the preparation of stereodefined phosphorothioate oligonucleotides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020512360A JP2020512360A (ja) | 2020-04-23 |
| JP2020512360A5 true JP2020512360A5 (cg-RX-API-DMAC7.html) | 2021-04-08 |
| JP7164540B2 JP7164540B2 (ja) | 2022-11-01 |
Family
ID=61899189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019553219A Expired - Fee Related JP7164540B2 (ja) | 2017-03-29 | 2018-03-20 | 立体的に規定されたホスホロチオエートオリゴヌクレオチドの調製のための直交保護基 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11591362B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3601309A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7164540B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20190135494A (cg-RX-API-DMAC7.html) |
| CN (1) | CN110475784B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018177825A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019002237A1 (en) | 2017-06-28 | 2019-01-03 | Roche Innovation Center Copenhagen A/S | METHOD OF MULTIPLE COUPLING AND OXIDATION |
| PL3717646T3 (pl) | 2017-12-01 | 2025-10-27 | The Texas A&M University System | Leczenie antysensowe zespołu angelmana |
| WO2020104492A1 (en) * | 2018-11-22 | 2020-05-28 | Roche Innovation Center Copenhagen A/S | Pyridinium salts as activators in the synthesis of stereodefined oligonucleotides |
| AU2020241559A1 (en) * | 2019-03-20 | 2021-11-11 | Wave Life Sciences Ltd. | Technologies useful for oligonucleotide preparation |
| CN113661168A (zh) * | 2019-04-16 | 2021-11-16 | 罗氏创新中心哥本哈根有限公司 | 用于制备核苷酸p(v)单体的新方法 |
| TW202241454A (zh) * | 2021-02-01 | 2022-11-01 | 日商第一三共股份有限公司 | 抗體-免疫賦活化劑共軛物之新穎製造方法 |
| CN116867795A (zh) * | 2021-02-01 | 2023-10-10 | 第一三共株式会社 | 抗体-免疫刺激剂偶联物的新型制造方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6465628B1 (en) | 1999-02-04 | 2002-10-15 | Isis Pharmaceuticals, Inc. | Process for the synthesis of oligomeric compounds |
| US6492171B2 (en) | 2000-05-16 | 2002-12-10 | Isis Pharmaceuticals, Inc. | Antisense modulation of TERT expression |
| WO2005092909A1 (ja) | 2004-03-25 | 2005-10-06 | Toudai Tlo, Ltd. | 立体規則性の高いリボヌクレオチド類縁体及びデオキシリボヌクレオチド類縁体の製造法 |
| DE602007009487D1 (de) | 2006-01-27 | 2010-11-11 | Isis Pharmaceutical Inc | 6-modifizierte bicyclische nukleinsäureanaloga |
| CA3042781C (en) | 2006-04-03 | 2021-10-19 | Roche Innovation Center Copenhagen A/S | Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| DK2205737T3 (da) | 2007-10-04 | 2013-05-21 | Santaris Pharma As | Mikromirer |
| US9290534B2 (en) | 2008-04-04 | 2016-03-22 | Ionis Pharmaceuticals, Inc. | Oligomeric compounds having at least one neutrally linked terminal bicyclic nucleoside |
| WO2010036698A1 (en) | 2008-09-24 | 2010-04-01 | Isis Pharmaceuticals, Inc. | Substituted alpha-l-bicyclic nucleosides |
| BRPI0923225A2 (pt) | 2008-12-02 | 2016-10-04 | Chiralgen Ltd | metodo para sintese de acidos nucleicos modificados no atomo de fosforo |
| EP2451461A4 (en) * | 2009-07-06 | 2013-05-29 | Ontorii Inc | NOVEL NUCLEIC ACID PRODRUGS AND METHOD OF USE THEREOF |
| DK2620428T3 (da) * | 2010-09-24 | 2019-07-01 | Wave Life Sciences Ltd | Asymmetrisk hjælpegruppe |
| DK2872147T3 (da) | 2012-07-13 | 2023-02-20 | Wave Life Sciences Ltd | Fremgangsmåde til fremstilling af kirale oligonukleotider |
| WO2017157672A1 (en) | 2016-03-18 | 2017-09-21 | Roche Innovation Center Copenhagen A/S | Acyl-protected l-lna-guanosine monomers |
| WO2017194498A1 (en) * | 2016-05-12 | 2017-11-16 | Roche Innovation Center Copenhagen A/S | Enhanced coupling of stereodefined oxazaphospholidine phosphoramidite monomers to nucleoside or oligonucleotide |
| EP3458464B1 (en) * | 2016-05-18 | 2026-04-15 | ETH Zurich | Stereoselective synthesis of phosphorothioate oligoribonucleotides |
-
2018
- 2018-03-20 KR KR1020197030981A patent/KR20190135494A/ko not_active Ceased
- 2018-03-20 US US16/497,952 patent/US11591362B2/en active Active
- 2018-03-20 EP EP18715527.0A patent/EP3601309A1/en not_active Withdrawn
- 2018-03-20 JP JP2019553219A patent/JP7164540B2/ja not_active Expired - Fee Related
- 2018-03-20 CN CN201880022722.3A patent/CN110475784B/zh active Active
- 2018-03-20 WO PCT/EP2018/057069 patent/WO2018177825A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7097820B2 (ja) | ヌクレオシドまたはオリゴヌクレオチドへの、立体的に規定されたオキサザホスホリジンホスホルアミダイト単量体のカップリングの増大法 | |
| CN112533892B (zh) | 烷氧基苯基衍生物、核苷保护体和核苷酸保护体、寡核苷酸制造方法以及取代基除去方法 | |
| JP4945129B2 (ja) | フルオラス担体およびそれを用いたオリゴヌクレオチド誘導体の製造方法 | |
| KR102372122B1 (ko) | 아실-보호된 l-lna-구아노신 단량체 | |
| JP7164540B2 (ja) | 立体的に規定されたホスホロチオエートオリゴヌクレオチドの調製のための直交保護基 | |
| JP2020525503A (ja) | 多重カップリングおよび酸化の方法 | |
| JP2011184318A (ja) | リボヌクレシドh−ボラノホスホネート | |
| JPH1072486A5 (cg-RX-API-DMAC7.html) | ||
| JP7698631B2 (ja) | 核酸オリゴマーの製造方法 | |
| CN115003682A (zh) | 核酸寡聚物的制造方法 | |
| EP4180442A1 (en) | Method for producing nucleic acid oligomer | |
| US12391716B2 (en) | Process of preparing nucleic acid oligomer | |
| EP4410770A1 (en) | Production method for purified dichloroacetic acid | |
| JP2008526918A5 (cg-RX-API-DMAC7.html) | ||
| KR20250046255A (ko) | 티오화 용액 | |
| US11667660B2 (en) | Pyridinium salts as activators in the synthesis of stereodefined oligonucleotides | |
| KR20250042734A (ko) | 올리고뉴클레오티드의 제조 방법 | |
| JP2020132604A (ja) | 核酸合成用固相担体及びそれを用いた核酸の製造方法 | |
| JP2008532946A5 (cg-RX-API-DMAC7.html) | ||
| US20130303745A1 (en) | Synthesis of oligonucleotides | |
| JP4797156B2 (ja) | リボヌクレオシドの2’水酸基の脱保護方法 | |
| EP4477659A1 (en) | Method for producing oligonucleotide | |
| WO2021177123A1 (ja) | 人工核酸 | |
| US20100081802A1 (en) | Synthesis of Phosphitylated Compounds Using a Quaternary Heterocyclic Activator | |
| HK40022416B (en) | Multiple coupling & oxidation method |